Daxas 500 micrograms film-coated tablets

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
Updated
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Roflumilast
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/10/636/001

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/002

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/003

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/004

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/005

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/006

500 microgram(s)

R03DX07

Tablet

EU/1/10/636/007

500 microgram(s)

R03DX07

Tablet

Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925
Medical Information E-mail:
mipqc.ireland@astrazeneca.com
Telephone:
+353 1 609 7100
Fax:
+353 1 686 5038
Website:
https://contactazmedical.astrazeneca.com
Medical Information Direct Line:
1800800899

Address: